EdwardCLauterbachMD

PubMed

• 8 citations
  Early psychiatric morbidity in a Brazilian sample of acute ischemic stroke patients
  Vinicius Sousa Pietra Pedroso, Andre R. Brunoni, Érica Leandro Marciano Vieira, Ricardo E. Jorge, Edward C. Lauterbach, Antônio Lúcio Teixeira> ;Clinics. 2018 Jan 1
• 4 citations
  Six psychotropics for pre-symptomatic & early Alzheimer's (MCI), Parkinson's, and Huntington's disease modification
  Edward C. Lauterbach> ;Neural Regeneration Research. 2016 Nov 1
• 19 citations
  Revisiting the neuropsychiatry of Huntington's disease.
  Antônio Lúcio Teixeira, Leonardo Cruz de Souza, Natalia Pessoa Rocha, Erin Furr-Stimming, Edward C. Lauterbach> ;Dementia & Neuropsychologia. 2016 Oct 1
• 18 citations
  Treatment Resistant Depression with Loss of Antidepressant Response: Rapid-Acting Antidepressant Action of Dextromethorphan, A Possible Treatment Bridging Molecule.
  Edward C. Lauterbach> ;Psychopharmacology Bulletin. 2016 Aug 15
• 17 citations
  Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease.
  Edward C. Lauterbach> ;American Journal of Neurodegenerative Disease. 2016 Mar 1
• 42 citations
  Neuroprotective effects of psychotropic drugs in Huntington's disease.
  Edward C. Lauterbach> ;International Journal of Molecular Sciences. 2013 Nov 15
• 4 citations
  Use of psychotropic medication in Alzheimer's disease is associated with more rapid cognitive and functional decline
  Edward C. Lauterbach> ;Evidence-Based Medicine. 2013 Oct 1
• 55 citations
  Toward a more precise, clinically—informed pathophysiology of pathological laughing and crying
  Edward C. Lauterbach, Jeffrey L. Cummings, Preetha Sharone Kuppuswamy> ;Neuroscience and Biobehavioral Reviews. 2013 Sep 1
• 12 citations
  Psychotropics regulate Skp1a, Aldh1a1, and Hspa8 transcription — Potential to delay Parkinson's disease
  Edward C. Lauterbach> ;Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2013 Jan 10
• 21 citations
  Psychiatric comorbidities of chronic migraine in community and tertiary care clinic samples.
  Antônio Lúcio Teixeira, Esther Angélica Coelho Costa, Ariovaldo Alberto da Silva, Igor Alvarenga Moreira dos Santos, Rodrigo Santiago Gomez, Arthur Kummer, Edward C. L...> ;The Journal of Headache and Pain. 2012 Sep 1
• 33 citations
  Agomelatine in depressive disorders: its novel mechanisms of action.
  Venkataramanujan Srinivasan, Rahimah Zakaria, Zahiruddin Othman, Edward C. Lauterbach, Darío Acuña-Castroviejo> ;The Journal of Neuropsychiatry and Clinical Neurosciences. 2012 Jul 1
• 38 citations
  An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan.
  Edward C. Lauterbach> ;Medical Hypotheses. 2012 Jun 1
• 86 citations
  Melatonin in Antinociception: Its Therapeutic Applications
  Venkatramanujam Srinivasan, Edward C. Lauterbach, Khek Yu Ho, Darío Acuña-Castroviejo, Rahimah Zakaria, Amnon Brzezinski> ;Current Neuropharmacology. 2012 May 31
• 16 citations
  Psychotropic drug effects on gene transcriptomics relevant to Parkinson's disease.
  Edward C. Lauterbach> ;Progress in Neuro-Psychopharmacology & Biological Psychiatry. 2012 Aug 7
• 6 citations
  Neuropsychiatry of Parkinson's disease
  Antônio Lúcio Teixeira, Leonardo F. Fontenelle, Edward C. Lauterbach, Sergio E. Starkstein> ;Parkinson's Disease. 2012 Apr 17
• 14 citations
  Psychotropic drug effects on gene transcriptomics relevant to Alzheimer disease.
  Edward C. Lauterbach> ;Alzheimer Disease and Associated Disorders. 2012 Jan 1
• 15 citations
  The neuroprotective disease-modifying potential of psychotropics in Parkinson's disease.
  Edward C. Lauterbach, Leonardo F. Fontenelle, Antônio Lúcio Teixeira> ;Parkinson's Disease. 2012 Jan 1
• 10 citations
  Obsessive-compulsive symptoms among patients with blepharospasm and hemifacial spasm.
  Leonardo F. Fontenelle, Paula G. Pacheco, Paula M. Nascimento, Andrea R. de Freitas, Ana Lúcia Zuma de Rosso, Antônio Lúcio Teixeira, Edward C. Lauterbach> ;General Hospital Psychiatry. 2011 Sep 1
• 20 citations
  Psychopharmacological Neuroprotection in Neurodegenerative Diseases, Part III: Criteria-Based Assessment: A Report of the ANPA Committee on Research
  Edward C. Lauterbach, Mario F. Mendez> ;The Journal of Neuropsychiatry and Clinical Neurosciences. 2011 Jul 1
• 261 citations
  Dextromethorphan as a potential rapid-acting antidepressant.
  Edward C. Lauterbach> ;Medical Hypotheses. 2011 May 1
• 13 citations
  Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.
  Edward C. Lauterbach, Preetha Sharone Kuppuswamy, Lauren L. Greenway> ;Neurocase. 2010 Sep 20
• 10 citations
  Mood and neurobehavioral correlates of cerebellar lesions.
  Edward C. Lauterbach, Julia B. Harris, William F. Bina> ;Cognitive and Behavioral Neurology. 2010 Jun 1
• 15 citations
  Psychopharmacological Neuroprotection in Neurodegenerative Disease: Heuristic Clinical Applications
  Edward C. Lauterbach, Samuel D. Shillcutt, Jeff Victoroff, Kerry L. Coburn, Mario F. Mendez> ;The Journal of Neuropsychiatry and Clinical Neurosciences. 2010 Apr 1
• 55 citations
  Psychopharmacological Neuroprotection in Neurodegenerative Disease: Assessing the Preclinical Data
  Edward C. Lauterbach, Jeff Victoroff, Kerry L. Coburn, Samuel D. Shillcutt, Suzanne M. Doonan, Mario F. Mendez> ;The Journal of Neuropsychiatry and Clinical Neurosciences. 2010 Jan 1
• 106 citations
  Neuroanatomy of Pathological Laughing and Crying: A Report of the American Neuropsychiatric Association Committee on Research
  Josef Parvizi, Kerry L. Coburn, Samuel D. Shillcutt, C. Edward Coffey, Edward C. Lauterbach, Mario F. Mendez> ;The Journal of Neuropsychiatry and Clinical Neurosciences. 2009 Jan 1
• Join now to see all